Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Predicted 10-Year Risk of Cardiovascular Disease in the Islamic Republic of Iran and the Body Mass Index Paradox; [Prediction Du Risque De Maladie Cardio-Vasculaire Sur Une Periode De 10 Ans En Republique Islamique D'iran, Et Paradoxe De L'indice De Masse Corporelle]
Majid Davari
Majid Davari

Associate Professor of Pharmacoeconomics and Pharmaceutical Administration

Department Pharmacoeconomics and Pharmaceutical Administration

School of Pharmacy

Pharmaceutical Management & Economics Research Center

Tehran University of Medical Sciences

Related Documents
1. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
All Documents
1. Cost-Effectiveness Analysis of Mechanical and Pharmaceutical Methods of Labor Induction in Pregnant Women in Iran, Medical Journal of the Islamic Republic of Iran (2025)
2. Cost-Utility Analysis of Combination Medical Therapies in Chronic Coronary Syndrome: A Comparative Study Using Real-World and Patient-Level Data From Iran, BMJ Open (2025)
3. Cost-Utility Analysis of Combination Medical Therapies in Chronic Coronary Syndrome: A Comparative Study Using Real-World and Patient-Level Data From Iran, BMJ Open (2025)
4. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
5. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
6. Efficacy of Probiotics in Overweight and Obesity Control: An Umbrella Review and Subgroup Meta-Analysis, Probiotics and Antimicrobial Proteins (2024)
7. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
8. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
9. Improving Access to Medicines to Reduce Marketing and Use of Substandard and Falsified Medicines in Africa: Scoping Review, Journal of Medicine Access (2024)
10. Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis, Iranian Journal of Medical Sciences (2023)
11. Utilization Trend of Parenteral Antidiabetic Drugs in Type 2 Diabetic Patients Covered by Iran Health Insurance Organization From 2011 to 2030, Iranian Journal of Public Health (2023)
12. A Comprehensive Review of Official Discount Rates in Guidelines of Health Economic Evaluations Over Time: The Trends and Roots, European Journal of Health Economics (2022)
13. Antihypertensive Prescribing Pattern, Prescriber Adherence to Ish 2020 Guidelines, and Implication of Outpatient Drug Price on Blood Pressure Control at Selected Hospitals in Southern Ethiopia, European Journal of Clinical Pharmacology (2022)
14. Antihypertensive Prescribing Pattern, Prescriber Adherence to Ish 2020 Guidelines, and Implication of Outpatient Drug Price on Blood Pressure Control at Selected Hospitals in Southern Ethiopia, European Journal of Clinical Pharmacology (2022)
15. Blood Pressure and Blood Glucose Control and Associated Factors Among Adults With Hypertension at Three Public Hospitals in Southern Ethiopia, High Blood Pressure and Cardiovascular Prevention (2022)
16. Blood Pressure and Blood Glucose Control and Associated Factors Among Adults With Hypertension at Three Public Hospitals in Southern Ethiopia, High Blood Pressure and Cardiovascular Prevention (2022)
17. Cost-Effectiveness of Hypertension Therapy Based on 2020 International Society of Hypertension Guidelines in Ethiopia From a Societal Perspective, PLoS ONE (2022)
18. Cost-Effectiveness of Hypertension Therapy Based on 2020 International Society of Hypertension Guidelines in Ethiopia From a Societal Perspective, PLoS ONE (2022)
19. Long-Term Cost-Effectiveness of Quality of Diabetes Care; Experiences From Private and Public Diabetes Centers in Iran, Health Economics Review (2022)
20. Medical Therapy Versus Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Stable Coronary Artery Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, ARYA Atherosclerosis (2022)
21. Medical Therapy Versus Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Stable Coronary Artery Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, ARYA Atherosclerosis (2022)
22. Paid and Unpaid Work Productivity Loss Associated With Treated Hypertension in Southern Ethiopia: A Patient-Level Analysis, Journal of Pharmaceutical Health Services Research (2022)
23. Paid and Unpaid Work Productivity Loss Associated With Treated Hypertension in Southern Ethiopia: A Patient-Level Analysis, Journal of Pharmaceutical Health Services Research (2022)
24. Quality of Care in Type 2 Diabetes in Iran; a Cross-Sectional Study Using Patient-Level Data, BMC Endocrine Disorders (2022)
25. Societal Economic Burden of Hypertension at Selected Hospitals in Southern Ethiopia: A Patient-Level Analysis, BMJ Open (2022)
26. Societal Economic Burden of Hypertension at Selected Hospitals in Southern Ethiopia: A Patient-Level Analysis, BMJ Open (2022)
27. Correction To: Eliciting the Public Preferences for Pharmaceutical Subsidy in Iran: A Discrete Choice Experiment Study (Journal of Pharmaceutical Policy and Practice, (2021), 14, 1, (59), 10.1186/S40545-021-00345-4), Journal of Pharmaceutical Policy and Practice (2021)
28. Eliciting the Public Preferences for Pharmaceutical Subsidy in Iran: A Discrete Choice Experiment Study, Journal of Pharmaceutical Policy and Practice (2021)
29. Pharmaceutical Subsidy Policy in Iran: A Qualitative Stakeholder Analysis, Health Research Policy and Systems (2021)
30. Reasons for Poor Blood Pressure Control in Eastern Sub-Saharan Africa: Looking Into 4P’S (Primary Care, Professional, Patient, and Public Health Policy) for Improving Blood Pressure Control: A Scoping Review, BMC Cardiovascular Disorders (2021)
31. Reasons for Poor Blood Pressure Control in Eastern Sub-Saharan Africa: Looking Into 4P’S (Primary Care, Professional, Patient, and Public Health Policy) for Improving Blood Pressure Control: A Scoping Review, BMC Cardiovascular Disorders (2021)
32. Risk of Fatal and Nonfatal Coronary Heart Disease and Stroke Events Among Adult Patients With Hypertension: Basic Markov Model Inputs for Evaluating Cost-Effectiveness of Hypertension Treatment: Systematic Review of Cohort Studies, Journal of Pharmaceutical Health Services Research (2021)
33. Risk of Fatal and Nonfatal Coronary Heart Disease and Stroke Events Among Adult Patients With Hypertension: Basic Markov Model Inputs for Evaluating Cost-Effectiveness of Hypertension Treatment: Systematic Review of Cohort Studies, Journal of Pharmaceutical Health Services Research (2021)
34. Antiretroviral Therapy and the Risk of Sexual Transmission of Hiv: A Systematic Review and Meta-Analysis, HIV Medicine (2020)
35. Cost-Effectiveness Analysis of Enzyme Replacement Therapy (Ert) for Treatment of Infantile-Onset Pompe Disease (Iopd) in the Iranian Pharmaceutical Market, Intractable and Rare Diseases Research (2020)
36. Cost-Effectiveness of Interventional Therapies for Management of Treatment-Resistant Hypertension: Systematic Review of Pharmacoeconomic Studies, Journal of Pharmaceutical Health Services Research (2020)
37. Cost-Effectiveness of Interventional Therapies for Management of Treatment-Resistant Hypertension: Systematic Review of Pharmacoeconomic Studies, Journal of Pharmaceutical Health Services Research (2020)
38. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2020)
39. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2020)
40. Pregabalin and Gabapentin in Neuropathic Pain Management After Spinal Cord Injury: A Systematic Review and Meta-Analysis, Korean Journal of Pain (2020)
41. Why Healthcare Market Needs Government Intervention to Improve Access to Essential Medicines and Healthcare Efficiency: A Scoping Review From Pharmaceutical Price Regulation Perspective, Journal of Pharmaceutical Health Services Research (2020)
42. A Cost-Effectiveness Analysis of Albumin in Septic Shock: A Patient-Level Data Analysis, Clinical Therapeutics (2019)
43. Evaluation of Urban and Rural Family Physician Program in Iran: A Systematic Review, Iranian Journal of Public Health (2019)
44. Health Status and Quality of Life in Patients With Severe Hemophilia A: A Cross-Sectional Survey, Hematology Reports (2019)
45. Healthcare Resource Utilization and Cost of Care for Gaucher Patients in Iran, Journal of Diabetes and Metabolic Disorders (2019)
46. Healthcare Resource Utilization and the Cost of Care for Mps-I Patients in Iran, Value in Health Regional Issues (2019)
47. Is Albumin-Based Resuscitation in Severe Sepsis and Septic Shock Justifiable? an Evidence From a Cost-Effectiveness Evaluation, Ethiopian journal of health sciences (2019)
48. Response to Letter to the Editor: Fluid Volume, Fluid Balance and Patient Outcome in Severe Sepsis and Septic Shock: A Systematic Review, Journal of Critical Care (2019)
49. Safety and Effectiveness of Mre in Comparison With Cte in Diagnosis of Adult Crohn's Disease, Medical Journal of the Islamic Republic of Iran (2019)
50. Socioeconomic Status, Cardiac Risk Factors, and Cardiovascular Disease: A Novel Approach to Determination of This Association, ARYA Atherosclerosis (2019)
51. Socioeconomic Status, Cardiac Risk Factors, and Cardiovascular Disease: A Novel Approach to Determination of This Association, ARYA Atherosclerosis (2019)
52. Factors Influencing Prescribing Decisions of Physicians: A Review, Ethiopian journal of health sciences (2018)
53. Fluid Volume, Fluid Balance and Patient Outcome in Severe Sepsis and Septic Shock: A Systematic Review, Journal of Critical Care (2018)
54. Effectiveness of Trastuzumab As Adjuvant Therapy in Patients With Early Stage Breast Cancer: A Systematic Review and Meta-Analysis, Medical Journal of the Islamic Republic of Iran (2017)
55. Effectiveness of Trastuzumab As Adjuvant Therapy in Patients With Early Stage Breast Cancer: A Systematic Review and Meta-Analysis, Medical Journal of the Islamic Republic of Iran (2017)
56. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2017)
57. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2017)
58. Coverage Decision-Making for Orthopedics Interventions in the Health Transformation Program in Iran: A Multiple Criteria Decision Analysis (Mcda), Shiraz E Medical Journal (2016)
59. Health Care Resource Utilization and Cost of Care for Haemophilia a and B Patients in Iran, Transfusion and Apheresis Science (2016)
60. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2016)
61. Newborn Screening for Galactosaemia, Cochrane Database of Systematic Reviews (2016)
62. The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study, International Journal of Preventive Medicine (2016)
63. The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study, International Journal of Preventive Medicine (2016)
64. Cost‑Effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market, International Journal of Preventive Medicine (2015)
65. Cost‑Effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market, International Journal of Preventive Medicine (2015)
66. Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development, Iranian Journal of Pharmaceutical Research (2015)
67. Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development, Iranian Journal of Pharmaceutical Research (2015)
68. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data From a Cancer Specific Hospital in Isfahan, International Journal of Preventive Medicine (2013)
69. Health Care Financing in Iran; Is Privatization a Good Solution?, Iranian Journal of Public Health (2012)
70. Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?, Iranian Journal of Pharmaceutical Research (2012)
71. The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data From a Cancer Specific Hospital in Isfahan, International Journal of Preventive Medicine (2012)
72. The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran, International Journal of Preventive Medicine (2012)
73. The Iranian Health Insurance System; Past Experiences, Present Challenges and Future Strategies, Iranian Journal of Public Health (2012)
74. Comparative Study on Cost and Effects of Non Invasive Helicobacter Pylori Diagnostic Tests, Journal of Isfahan Medical School (2011)
75. Cost-Effectiveness Analysis of Colorectal Cancer Screening Methods in Iran, Archives of Iranian Medicine (2011)
76. Pharmaceutical Policy and Market in Iran: Past Experiences and Future Challenges, Journal of Pharmaceutical Health Services Research (2011)
77. Sensitivity and Specificity of Colorectal Cancer Mass Screening Methods: A Systematic Review of the Literature, Iranian Journal of Cancer Prevention (2011)